6618:HKEXJD Health International, Inc. Analysis
Data as of 2026-09-17 - not real-time
HK$34.30
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
At HKD 34.30, JD Health International Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 12.9% over the past 30 days. Relative strength is 33.0 — approaching oversold — and the MACD signal is bearish. Watch HKD 33.88 as support and HKD 39.84 as the nearer resistance level.
The shares look undervalued, trading on 15.1 times earnings below a sector average of 30.0. Analyst price targets sit 99.4% above the current price. Revenue is growing at 15.9% on a 7.9% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 26.6%, a beta of 0.29 and a maximum drawdown of 54.1%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
The shares look undervalued, trading on 15.1 times earnings below a sector average of 30.0. Analyst price targets sit 99.4% above the current price. Revenue is growing at 15.9% on a 7.9% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 26.6%, a beta of 0.29 and a maximum drawdown of 54.1%, position sizing matters here. The wider market backdrop reads extreme greed at 90 on the fear-greed composite.
Timeframes disagree: the short-term read is hold while the long-term read is buy, conviction 5 out of 10.
Top Market Events
Seeking Alpha1monJD Health International Inc.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 47.74
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked below long-term ones
- P/E of 15.1 versus sector average of 30.0
- Trading below the 200-day average of 47.74
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- P/E of 15.1 versus sector average of 30.0
- Analyst targets imply +99.4% versus the current price
- Revenue growth of +15.9%
Key Metrics & Analysis
Financial Health
Revenue Growth15.90%
Profit Margin7.86%
P/E Ratio15.1
ROE10.40%
ROA3.73%
Debt/Equity1.42
P/B Ratio1.5
Op. Cash FlowHK$8.4B
Free Cash FlowHK$5.4B
Industry P/E30.0
Technical Analysis
TrendBearish
RSI33.0
SupportHK$33.88
ResistanceHK$39.84
MA 20HK$36.38
MA 50HK$37.66
MA 200HK$47.74
MACDBearish
VolumeDecreasing
Fear & Greed Index89.8
Valuation
Fair ValueHK$55.23
Target PriceHK$68.41
Upside/Downside99.45%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.29
Volatility26.58%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
601816
Beijing-Shanghai High-Speed Railway Co., Ltd. Class A
STOCK601991
Datang International Power Generation Co., Ltd. Class A
STOCK002594
BYD Company Limited Class A
STOCK601818
China Everbright Bank Co., Ltd. Class A
STOCK600025
Huaneng Lancang River Hydropower Co Ltd Class A
STOCK688180
Shanghai Junshi Biosciences Co., Ltd. Class A
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.